Mansalinog, Emilyn B.

HRN: 22-26-8401  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2023
METRONIDAZOLE 500MG (TAB)
01/02/2023
01/08/2023
ORAL
500 Mg
TID
AMOEBIASIS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: